118 related articles for article (PubMed ID: 5344871)
1. Effect of the ethyl ester and sodium salt of alpha-p-chlorophenoxyisobutyric acid on cholesterol oxidation by rat liver mitochondria.
Kritchevsky D; Tepper SA; Sallata P; Kabakjian JR; Cristofalo VJ
Proc Soc Exp Biol Med; 1969 Oct; 132(1):79-82. PubMed ID: 5344871
[No Abstract] [Full Text] [Related]
2. Oxidation of cholesterol by rat liver mitochondria: effect of N-gamma-phenylpropyl-N-benzyloxy acetamide.
Kritchevsky D; Tepper SA
Arzneimittelforschung; 1970 Apr; 20(4):584-5. PubMed ID: 5467828
[No Abstract] [Full Text] [Related]
3. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
Timms AR; Kelly LA; Ho RS; Trapold JH
Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
[No Abstract] [Full Text] [Related]
4. Effect of 2-acetoamidoethyl (p-chlorophenyl) (m-trifluoromethylphenoxy) acetate (halofenate) on cholesterol oxidation by rat liver mitochondria.
Kritchevsky D; Tepper SA
Proc Soc Exp Biol Med; 1972 Apr; 139(4):1284-7. PubMed ID: 5023326
[No Abstract] [Full Text] [Related]
5. Increase of hepatic mitochondria on administration of ethyl alpha-p-chlorophenoxyisobutyrate to the rat.
Kurup CK; Aithal HN; Ramasarma T
Biochem J; 1970 Mar; 116(5):773-9. PubMed ID: 5441366
[TBL] [Abstract][Full Text] [Related]
6. The effect of ethyl alpha-p. chlorophenoxyisobutyrate on ethanol-induced hepatic steatosis in the rat.
Brown DF
Metabolism; 1966 Oct; 15(10):868-73. PubMed ID: 5923523
[No Abstract] [Full Text] [Related]
7. The hypocholesterolemic action of eritadenine in the rat.
Takashima K; Izumi K; Iwai H; Takeyama S
Atherosclerosis; 1973; 17(3):491-502. PubMed ID: 4736648
[No Abstract] [Full Text] [Related]
8. Morphological and biochemical changes in rat liver during the early stages of ethyl chlorophenoxyisobutyrate administration.
Kaneko A; Sakamoto S; Morita M; Onoe T
Tohoku J Exp Med; 1969 Sep; 99(1):81-101. PubMed ID: 4390771
[No Abstract] [Full Text] [Related]
9. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat.
Hess R; Stäubli W; Riess W
Nature; 1965 Nov; 208(5013):856-8. PubMed ID: 5870099
[No Abstract] [Full Text] [Related]
10. The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzalecene. I. The metabolism of free fatty acid-albumin complex by the isolated perfused liver.
Mishkel MA; Webb WF
Biochem Pharmacol; 1967 May; 16(5):897-905. PubMed ID: 6036737
[No Abstract] [Full Text] [Related]
11. Effect of N-gamma-phenylpropyl-N-benzyloxy acetamide (W-1372) and of clofibrate on the lipids of normal and hypercholesteremic rats.
Berger FM; Douglas JF; Lu GG; Ludwig BJ
Proc Soc Exp Biol Med; 1969 Oct; 132(1):293-7. PubMed ID: 5344849
[No Abstract] [Full Text] [Related]
12. Effect of administration of alpha-p-chlorophenoxyisobutyrate on hepatic mitochondria and ubiquinone during cold exposure.
Inamdar AR; Sharma BV; Aithal HN; Ramakrishna Kurup CK; Padayatty JD; Ramasarma T
Indian J Biochem; 1970 Mar; 7(1):9-12. PubMed ID: 4248109
[No Abstract] [Full Text] [Related]
13. Relation of cholanate structure to inhibition of 14C-26-cholesterol oxidation by mitochondria from rat liver.
Inkpen JA; Inkpen CA; Quackenbush FW
Lipids; 1970 Jan; 5(1):76-9. PubMed ID: 5418210
[No Abstract] [Full Text] [Related]
14. Further studies concerning the effects of clofibrate on respiration and oxidative phosphorylation of rat liver mitochondria.
Mackerer CR; Haettinger JR
Biochem Pharmacol; 1974 Dec; 23(23):3331-45. PubMed ID: 4374218
[No Abstract] [Full Text] [Related]
15. Effect of chlorophenoxyisobutyrate on the metabolism of endogenous glycerides in man.
Sodhi HS; Kudchodkar BJ; Horlick L
Metabolism; 1971 Mar; 20(3):309-18. PubMed ID: 5546926
[No Abstract] [Full Text] [Related]
16. STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE).
AZARNOFF DL; TUCKER DR; BARR GA
Metabolism; 1965 Sep; 14():959-65. PubMed ID: 14327272
[No Abstract] [Full Text] [Related]
17. Studies on new nicotinic acid ester derivatives. 6. Serum cholesterol level lowering effect of 2,2,6,6-tetrakis(nicotinoyloxymethyl) cyclohexanol (K-31).
Aso Y; Abe Y; Higo K; Naruke T; Irikura T
J Atheroscler Res; 1969; 10(3):391-401. PubMed ID: 5364087
[No Abstract] [Full Text] [Related]
18. [Derivatives of para-chlorphenoxyisobutyric acid as hypocholesteremic agents].
Klebanov BM
Farmakol Toksikol; 1970; 33(3):324-7. PubMed ID: 5453029
[No Abstract] [Full Text] [Related]
19. Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
Gallt C; Edwards KD; Paoletti R
Life Sci II; 1970 May; 9(9):523-34. PubMed ID: 5452796
[No Abstract] [Full Text] [Related]
20. Influence of ethyl p-chlorophenoxyisobutyrate (CPIB) upon establishment and progression of experimental atherosclerosis in rabbits.
Kritchevsky D; Sallata P; Tepper SA
J Atheroscler Res; 1968; 8(5):755-61. PubMed ID: 5688373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
